Epidemiology of SLE in Italy: an observational study using a primary care database.

IF 3.7 2区 医学 Q1 RHEUMATOLOGY Lupus Science & Medicine Pub Date : 2024-05-13 DOI:10.1136/lupus-2024-001162
Pietro Ferrara, Ippazio C Antonazzo, Manuel Zamparini, Carla Fornari, Cristiana Borrelli, Silvia Boarino, Alessandra Bettiol, Irene Mattioli, Pasquale Palladino, Elena Zanzottera Ferrari, Giacomo Emmi, Lorenzo G Mantovani, Giampiero Mazzaglia
{"title":"Epidemiology of SLE in Italy: an observational study using a primary care database.","authors":"Pietro Ferrara, Ippazio C Antonazzo, Manuel Zamparini, Carla Fornari, Cristiana Borrelli, Silvia Boarino, Alessandra Bettiol, Irene Mattioli, Pasquale Palladino, Elena Zanzottera Ferrari, Giacomo Emmi, Lorenzo G Mantovani, Giampiero Mazzaglia","doi":"10.1136/lupus-2024-001162","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To estimate the incidence and prevalence of SLE in Italy, and to describe the demographic and clinical characteristics of patients with newly diagnosed SLE.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using The Health Improvement Network general practice database in Italy, encompassing data from 634 753 people. SLE cases were identified over the period 2017-2022, employing three alternative definitions to provide a more detailed understanding of SLE characteristics. Incidence rates were expressed as cases per 100 000 person-years and prevalence as cases per 100 000 people. Demographic and clinical characteristics of incident SLE cases were also studied.</p><p><strong>Results: </strong>From 2017 to 2022, a total of 191 incident and 1385 prevalent cases were identified under our first definition. In 2022, the incidence rate was 6.51 cases (95% CI 6.29 to 6.74) per 100 000 person-years, and the prevalence 60.57 (95% CI 59.89 to 61.25) per 100 000 people, being the prevalence five times higher in women compared with men. Both estimates have trended upwards since 2017. A geographical variation across the country was also seen. The demographic and clinical characteristics of incident SLE cases were described, while the potential associations of SLE incidence with some pre-existing conditions were observed, such as chronic kidney disease, chronic hepatic disease, rheumatoid arthritis and Sjogren's syndrome.</p><p><strong>Conclusions: </strong>The results of this nationwide study, the first conducted in Italy, showed that the incidence of SLE has increased in Italy in recent years. Age, sex, and area of residence strongly correlate with the epidemiology of this condition.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"11 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097856/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2024-001162","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To estimate the incidence and prevalence of SLE in Italy, and to describe the demographic and clinical characteristics of patients with newly diagnosed SLE.

Methods: A retrospective cohort study was conducted using The Health Improvement Network general practice database in Italy, encompassing data from 634 753 people. SLE cases were identified over the period 2017-2022, employing three alternative definitions to provide a more detailed understanding of SLE characteristics. Incidence rates were expressed as cases per 100 000 person-years and prevalence as cases per 100 000 people. Demographic and clinical characteristics of incident SLE cases were also studied.

Results: From 2017 to 2022, a total of 191 incident and 1385 prevalent cases were identified under our first definition. In 2022, the incidence rate was 6.51 cases (95% CI 6.29 to 6.74) per 100 000 person-years, and the prevalence 60.57 (95% CI 59.89 to 61.25) per 100 000 people, being the prevalence five times higher in women compared with men. Both estimates have trended upwards since 2017. A geographical variation across the country was also seen. The demographic and clinical characteristics of incident SLE cases were described, while the potential associations of SLE incidence with some pre-existing conditions were observed, such as chronic kidney disease, chronic hepatic disease, rheumatoid arthritis and Sjogren's syndrome.

Conclusions: The results of this nationwide study, the first conducted in Italy, showed that the incidence of SLE has increased in Italy in recent years. Age, sex, and area of residence strongly correlate with the epidemiology of this condition.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
意大利系统性红斑狼疮的流行病学:一项利用初级保健数据库进行的观察性研究。
目的估计系统性红斑狼疮在意大利的发病率和流行率,并描述新确诊系统性红斑狼疮患者的人口统计学和临床特征:利用意大利健康改善网络全科医生数据库(The Health Improvement Network general practice database)开展了一项回顾性队列研究,共收集了634 753人的数据。研究采用了三种不同的定义,以更详细地了解系统性红斑狼疮的特征。发病率以每十万人年的病例数表示,患病率以每十万人的病例数表示。此外,还研究了系统性红斑狼疮发病病例的人口统计学和临床特征:从 2017 年到 2022 年,根据我们的第一种定义,共发现了 191 例发病病例和 1385 例流行病例。2022年,发病率为每10万人年6.51例(95% CI 6.29至6.74),患病率为每10万人60.57例(95% CI 59.89至61.25),女性患病率是男性的5倍。自 2017 年以来,这两项估计值均呈上升趋势。此外,全国各地还存在地域差异。研究描述了系统性红斑狼疮发病病例的人口统计学和临床特征,同时观察了系统性红斑狼疮发病率与一些原有疾病的潜在关联,如慢性肾病、慢性肝病、类风湿性关节炎和斯约格伦综合征:这项首次在意大利进行的全国性研究结果表明,近年来系统性红斑狼疮在意大利的发病率有所上升。年龄、性别和居住地区与该病的流行病学密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lupus Science & Medicine
Lupus Science & Medicine RHEUMATOLOGY-
CiteScore
5.30
自引率
7.70%
发文量
88
审稿时长
15 weeks
期刊介绍: Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
期刊最新文献
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren's disease: Prepcov multicentre trial. Systematic review of the reporting of extrarenal manifestations in observational studies of Saudi patients with systemic lupus erythematosus. Meeting report: The Systemic Lupus International Collaborating Clinics (SLICC) World Lupus Seminar on Africa. Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden. Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1